RSC Advances · 2020 · 24 citations · 26 references
MedicineBioengineeringBiomedical EngineeringBiomaterialsBone GraftingDrug DeliveryBioactive GlassesBone Graft MaterialsBone Graft SubstitutesBone Tissue EngineeringImplant MaterialsScaffold DesignBioactive Scaffold MaterialsBone Regeneration MaterialsNew Bone FormationOrthopedic ImplantsOsteoconductive MaterialsOsteoinductive MaterialsSustained Release BiomaterialsSustained Release Implants
The treatment of bone defects caused by various reasons is still a major problem in orthopedic clinical work. Many studies on osteogenic implant materials have used various biologically active factors such as osteogenic inducers, but these biologically active factors have various side effects. Therefore, in this study, silk fibroin (SF) was used as a scaffold material, mesoporous bioactive glass nanoparticles (MBGNs) as a sustained release carrier, and the traditional Chinese drug icariin (ICA) was loaded to promote bone formation. The experiments in this study have proven that SF/MBGNs-ICA scaffolds can successfully load and release ICA for a long time, and the sustained-release ICA can promote the proliferation and differentiation of BMSCs for a long time. This controlled-release ICA organic/inorganic two-component scaffold material is expected to become a new bone grafting solution.
26
Triblock Copolymer Syntheses of Mesoporous Silica with Periodic 50 to 300 Angstrom Pores
Dongyuan Zhao, Jianglin Feng, Qisheng Huo et al. · Science · 1998 · 11.6K citations
The inflammatory responses to silk films in vitro and in vivo
Lorenz Meinel, Sandra Hofmann, Vassilis Karageorgiou et al. · Biomaterials · 2004 · 780 citations